Literature DB >> 24103724

Nanobodies - from llamas to therapeutic proteins.

.   

Abstract

Entities:  

Year:  2010        PMID： 24103724     DOI： 10.1016/j.ddtec.2010.03.002

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN： 1740-6749


× No keyword cloud information.
  20 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 2.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

3.  Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody.

Authors:  Kobra Omidfar; Fatemeh Sadat Amjad Zanjani; Arghavan Golbaz Hagh; Maedeh Darziani Azizi; Seyed Javad Rasouli; Susan Kashanian
Journal:  Mol Biol Rep       Date:  2013-09-20       Impact factor: 2.316

Review 4.  Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review.

Authors:  Kyungah Suh; Isaac Kyei; David S Hage
Journal:  J Sep Sci       Date:  2022-03-10       Impact factor: 3.614

5.  Use of the single cell gel electrophoresis (comet assay) for comparing apoptotic effect of conventional antibodies versus nanobodies.

Authors:  Ghada H Shaker; Nahla A Melake
Journal:  Saudi Pharm J       Date:  2011-12-02       Impact factor: 4.330

6.  High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement.

Authors:  Evelyn De Tavernier; Laurent Detalle; Erika Morizzo; Annelies Roobrouck; Severine De Taeye; Melanie Rieger; Tom Verhaeghe; Andreia Correia; Rob Van Hegelsom; Rita Figueirido; Jeroen Noens; Søren Steffensen; Thomas Stöhr; Willem Van de Velde; Erik Depla; Bruno Dombrecht
Journal:  J Biol Chem       Date:  2016-05-20       Impact factor: 5.157

7.  Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor.

Authors:  Ge Zhang; Lei Wang; Honglian Cui; Xiaomin Wang; Ganlin Zhang; Juan Ma; Huamin Han; Wen He; Wei Wang; Yunfeng Zhao; Changzhen Liu; Meiyi Sun; Bin Gao
Journal:  Sci Rep       Date:  2014-01-06       Impact factor: 4.379

8.  Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome.

Authors:  Soraya S Pereira; Leandro S Moreira-Dill; Michelle S S Morais; Nidiane D R Prado; Marcos L Barros; Andrea C Koishi; Giovanny A C A Mazarrotto; Giselle M Gonçalves; Juliana P Zuliani; Leonardo A Calderon; Andreimar M Soares; Luiz H Pereira da Silva; Claudia N Duarte dos Santos; Carla F C Fernandes; Rodrigo G Stabeli
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

Review 9.  Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.

Authors:  Yaozhong Hu; Changxiao Liu; Serge Muyldermans
Journal:  Front Immunol       Date:  2017-11-02       Impact factor: 7.561

10.  Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function.

Authors:  Fatemeh Kazemi-Lomedasht; Serge Muyldermans; Mahdi Habibi-Anbouhi; Mahdi Behdani
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.